Jinshi Asia Pharmaceutical announced that the company's board of directors reviewed and passed the bill and agreed to relinquish the priority purchase rights for the share transfer of the participating company, Bosheng Semiconductor Technology Co., Ltd. Zhang Mintao, a shareholder of Glass Core, plans to transfer his 90,000 yuan of registered capital to Lui Yixi, the company's vice chairman and shareholder holding 13.59% of the shares at 46.79 yuan per registered capital, for a total transfer price of 4.211,000 yuan. After the transfer is completed, the company's shareholding ratio in Glasscore will not change, and it will form a joint investment with Kuai Yixi. This transaction constitutes a related transaction. Within the approval authority of the board of directors, there is no need to submit it to the shareholders' meeting for review, and it does not constitute a major asset restructuring.

Jinshi Asia Pharmaceutical announced that the company's board of directors reviewed and passed the bill and agreed to relinquish the priority purchase rights for the share transfer of the participating company, Bosheng Semiconductor Technology Co., Ltd. Zhang Mintao, a shareholder of Glass Core, plans to transfer his 90,000 yuan of registered capital to Lui Yixi, the company's vice chairman and shareholder holding 13.59% of the shares at 46.79 yuan per registered capital, for a total transfer price of 4.211,000 yuan. After the transfer is completed, the company's shareholding ratio in Glasscore will not change, and it will form a joint investment with Kuai Yixi. This transaction constitutes a related transaction. Within the approval authority of the board of directors, there is no need to submit it to the shareholders' meeting for review, and it does not constitute a major asset restructuring.